Related Experiment Videos
[Fresh amniotic membrane transplantation for ocular surface diseases]
Hai-yan Luo1, Shu-min Peng, Yong-jian Wang
1Department of Ophthalmology, Second People's Hospital of Fuling District, Chongqing 408000, China.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA
|May 20, 2003
Summary
Fresh amniotic membrane transplantation effectively treats ocular surface disorders, showing no graft rejection or recurrence in pterygium and corneal ulcer cases. This procedure restores ocular function, particularly in severe symblepharon.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Tissue Engineering
Context:
- Ocular surface disorders (OSDs) present significant challenges in restoration.
- Traditional treatments may have limitations in efficacy and recurrence rates.
- Fresh amniotic membrane offers a biological scaffold for ocular surface reconstruction.
Purpose:
- To evaluate the therapeutic efficacy of fresh amniotic membrane transplantation for various ocular surface disorders.
- To assess graft survival, rejection rates, and recurrence of disease post-transplantation.
- To determine the functional recovery of ocular structures following the procedure.
Summary:
- Fresh amniotic membrane transplantation was performed on 52 eyes across 38 patients with conditions including pterygium, Mooren's ulcer, viral keratitis, and symblepharon.
- Follow-up periods ranged from 3 to 12 months, with no observed acute graft rejection.
- Successful outcomes included no recurrence of pterygium or corneal ulcers and restored ocular movement in severe symblepharon cases.
Impact:
- Fresh amniotic membrane serves as a viable graft material for ocular surface reconstruction.
- The study highlights the importance of complete pathological tissue removal and secure graft fixation for successful outcomes.
- This transplantation technique shows promise for improving patient vision and quality of life in OSDs.